Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cookson

Showing results (191-200 of 388) with videos related to

Pageof 39
Sort By:
Science (New York, N.Y.)|April 16, 2026
Sex effects on gene expression across the human cerebral cortex at cell type resolutionAlex R DeCasien, Pavan Auluck, Siyuan Liu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 15, 2002
An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damageTodd B Sherer, Ranjita Betarbet, Amy K Stout, et al.
Cell Reports|January 12, 2017
Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain AgingLilach Soreq, , , et al.
Neuroscience Letters|April 6, 2001
Cultured glial cells are resistant to the effects of motor neurone disease-associated SOD1 mutationsR E Williams, M R Cookson, A E Fray, et al.
Journal of Cellular and Molecular Medicine|August 23, 2018
Reduction of PINK1 or DJ-1 impair mitochondrial motility in neurites and alter ER-mitochondria contactsCristina Parrado-Fernández, Bernadette Schneider, Maria Ankarcrona, et al.
The European Journal of Neuroscience|October 10, 1998
The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical studyA E Fray, P G Ince, S J Banner, et al.
Cellular and Molecular Life Sciences : CMLS|November 25, 2019
Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDACAmandine Rovini, Philip A Gurnev, Alexandra Beilina, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2009
Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's diseaseZhihua Liu, Robin K Meray, Tom N Grammatopoulos, et al.
The American Journal of Pathology|July 25, 2009
Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synucleinWai Haung Yu, Beatriz Dorado, Helen Yvette Figueroa, et al.
Cellular and Molecular Life Sciences : CMLS|January 11, 2020
Correction to: Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDACAmandine Rovini, Philip A Gurnev, Alexandra Beilina, et al.
Pageof 39

Showing results (191-200 of 388) with videos related to

Sort By:
Pageof 39
Science (New York, N.Y.)|April 16, 2026
Sex effects on gene expression across the human cerebral cortex at cell type resolutionAlex R DeCasien, Pavan Auluck, Siyuan Liu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 15, 2002
An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damageTodd B Sherer, Ranjita Betarbet, Amy K Stout, et al.
Cell Reports|January 12, 2017
Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain AgingLilach Soreq, , , et al.
Neuroscience Letters|April 6, 2001
Cultured glial cells are resistant to the effects of motor neurone disease-associated SOD1 mutationsR E Williams, M R Cookson, A E Fray, et al.
Journal of Cellular and Molecular Medicine|August 23, 2018
Reduction of PINK1 or DJ-1 impair mitochondrial motility in neurites and alter ER-mitochondria contactsCristina Parrado-Fernández, Bernadette Schneider, Maria Ankarcrona, et al.
The European Journal of Neuroscience|October 10, 1998
The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical studyA E Fray, P G Ince, S J Banner, et al.
Cellular and Molecular Life Sciences : CMLS|November 25, 2019
Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDACAmandine Rovini, Philip A Gurnev, Alexandra Beilina, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2009
Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's diseaseZhihua Liu, Robin K Meray, Tom N Grammatopoulos, et al.
The American Journal of Pathology|July 25, 2009
Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synucleinWai Haung Yu, Beatriz Dorado, Helen Yvette Figueroa, et al.
Cellular and Molecular Life Sciences : CMLS|January 11, 2020
Correction to: Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDACAmandine Rovini, Philip A Gurnev, Alexandra Beilina, et al.
Pageof 39